American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults

Journal of the American Geriatrics Society

Volumn 63, Issue 11, 2015, Pages 2227-2246

  Samuel, Mary Jordan ^a  

^a American Geriatrics Society   (United States)

Author keywords

Beers Criteria; Beers List; drugs; medications; older adults; polypharmacy

Indexed keywords

AGED; AMERICAN GERIATRICS SOCIETY BEERS CRITERIA; ANTICHOLINERGIC EFFECT; ARTICLE; CONSENSUS DEVELOPMENT; DELPHI STUDY; DRUG INTERACTION; EVIDENCE BASED PRACTICE; HUMAN; INAPPROPRIATE PRESCRIBING; KIDNEY FUNCTION; MEDICAL EXPERT; MEDICAL SOCIETY; MEDICATION THERAPY MANAGEMENT; STANDARD; SYSTEMATIC REVIEW (TOPIC); GERIATRICS; POTENTIALLY INAPPROPRIATE MEDICATION; STANDARDS; UNITED STATES;

AGED; GERIATRICS; HUMANS; POTENTIALLY INAPPROPRIATE MEDICATION LIST; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84948419916     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13702     Document Type: Article

References (42)

1. Stockl KM, Le L, Zhang S, et al., Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care 2010; 16: e1-e10.
2. Fick DM, Mion LC, Beers MH, et al., Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008; 31: 42-51.
3. Patterson SM, Cadogan CA, Kerse N, et al., Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2014; 10: CD008165.
4. Tannenbaum C, Martin P, Tamblyn R, et al., Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Intern Med 2014; 174: 890-898.
5. Agostini JV, Zhang Y, Inouye SK,. Use of a computer-based reminder to improve sedative-hypnotic prescribing in older hospitalized patients. J Am Geriatr Soc 2007; 55: 43-48.
6. Graham R, Mancher M, Wolman DM, et al., Clinical Practice Guidelines We Can Trust. Washington, DC: Institute of Medicine National Academies Press, 2011.
7. The American Geriatrics Society Expert Panel on Postoperative. Delirium in Older Adults. American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc 2015; 63: 142-150.
8. Higgins JP, Altman DG, Gotzsche PC, et al., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
9. Jadad AR, Moore RA, Carroll D, et al., Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 1-12.
10. The GRADE working group. GRADE guidelines-best practicrs using the GRADE framework. J Clin Epidemiol [on-line]. Available at http://www.gradeworkinggroup.org/publications/jce-series.htm Accessed April 14, 2015.
11. Qaseem A, Snow V, Owens DK, et al., The development of clinical practice guidelines and guidance statements of the American College of Physicians: Summary of methods. Ann Intern Med 2010; 153: 194-199.
12. Hines LE, Murphy JE,. Potentially harmful drug-drug interactions in the elderly: A review. Am J Geriatr Pharmacother 2011; 9: 364-377.
13. Hanlon JT, Aspinall SL, Semla TP, et al., Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc 2009; 57: 335-340.
14. Duran CE, Azermai M, Vander Stichele RH,. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol 2013; 69: 1485-1496.
15. Campbell N, Boustani M, Limbil T, et al., The cognitive impact of anticholinergics: A clinical review. Clin Interv Aging 2009; 4: 225-233.
16. Rudolph JL, Salow MJ, Angelini MC, et al., The Anticholinergic Risk Scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008; 168: 508-513.
17. Carnahan RM, Lund BC, Perry PJ, et al., The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity. J Clin Pharmacol 2006; 46: 1481-1486.
18. Beers MH, Ouslander JG, Rollingher I, et al., Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825-1832.
19. Beers MH,. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531-1536.
20. Fick DM, Cooper JW, Wade WE, et al., Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a U.S. consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
21. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2012; 60: 616-631.
22. Berry SD, Lee Y, Cai S, et al., Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med 2013; 173: 754-761.
23. Hampton LM, Daubresse M, Chang HY, et al., Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry 2014; 71: 1006-1014.
24. Rolita L, Spegman A, Tang X, et al., Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc 2013; 61: 335-340.
25. Soderberg KC, Laflamme L, Moller J,. Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs 2013; 27: 155-161.
26. U.S. Government Accountability Office. Antipsychotic Drug Use: Report to Congressional Requesters. HHS Has Initiatives to Reduce Use among Older Adults in Nursing Homes, but Should Expand Efforts to Other Settings [on-line]. Available at http://www.gao.gov/assets/670/668221.pdf Accessed February 17, 2015.
27. Maust DT, Kim HM, Seyfried LS, et al., Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm. JAMA Psychiatry 2015; 72: 438-445.
28. Inouye SK, Marcantonio ER, Metzger ED,. Doing damage in delirium: The hazards of antipsychotic treatment in elderly persons. Lancet Psychiatry 2014; 1: 312-315.
29. Fox C, Smith T, Maidment I, et al., Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: A systematic review. Age Ageing 2014; 43: 604-615.
30. Gray SL, Anderson ML, Dublin S, et al., Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Intern Med 2015; 175: 401-407.
31. Charlesworth CJ, Smit E, Lee DS, et al., Polypharmacy among adults aged 65 years and older in the United States: 1988-2010. J Gerontol A Biol Sci Med Sci 2015; 70A: 989-995.
32. Davidoff AJ, Miller GE, Sarpong EM, et al., Prevalence of potentially inappropriate medication use in older adults using the 2012 Beers Criteria. J Am Geriatr Soc 2015; 63: 486-500.
33. Olfson M, King M, Schoenbaum M,. Benzodiazepine use in the United States. JAMA Psychiatry 2015; 72: 136-142.
34. Livingston G, Kelly L, Lewis-Holmes E, et al., Non-pharmacological interventions for agitation in dementia: Systematic review of randomised controlled trials. Br J Psychiatry 2014; 205: 436-442.
35. Resnick B, Kolanowski AM, Van Haitsma K,. Promoting positive behavioral health: A nonpharmacological toolkit for senior living communities. J Gerontol Nurs 2014; 40: 2-3.
36. Fick DM, DiMeglio B, McDowell JA, et al., Do you know your patient? Knowing individuals with dementia combined with evidence-based care promotes function and satisfaction in hospitalized older adults. J Gerontol Nurs 2013; 39: 2-4.
37. Hshieh TT, Yue J, Oh E, et al., Effectiveness of multicomponent nonpharmacological delirium interventions: A meta-analysis. JAMA Intern Med 2015; 175: 512-520.
38. McDowell JA, Mion LC, Lydon TJ, et al., A nonpharmacologic sleep protocol for hospitalized older patients. J Am Geriatr Soc 1998; 46: 700-705.
39. Kamdar BB, Yang J, King LM, et al., Developing, implementing, and evaluating a multifaceted quality improvement intervention to promote sleep in an ICU. Am J Med Qual 2014; 29: 546-554.
40. O'Mahony D, O'Sullivan D, Byrne S, et al., STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2015; 44: 213-218.
41. Renom-Guiteras A, Meyer G, Thurmann PA,. The EU(7)-PIM list: A list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol 2015; 71: 861-875.
42. Hanlon JT, Sloane RJ, Pieper CF, et al., Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients. Age Ageing 2011; 40: 274-277.